EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

One-year comparative effectiveness of bupropion and nicotine replacement therapy in smoking cessation: A prospective observational cohort study in Turkey

Neslisah Gurel Koksal, Mustafa Koksal

Pakistan Journal of Medical Sciences · 11.04.2026 · 42 (4) · 979-985

DOI: 10.12669/pjms.42.4.13527 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Pakistan Journal of Medical Sciences, online erschienen am 11.04.2026. Verfasst von Neslisah Gurel Koksal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Neslisah Gurel Koksal, MD Department of Family Medicine, Giresun University Giresun Training, Research Hospital, Giresun, Turkey. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Based on randomized clinical trials, bupropion and nicotine replacement therapy (NRT) are recommended as equally effective first-line pharmacotherapies for smoking cessation. However, long-term real-world observational data comparing these two treatment options are scarce. This study aimed to evaluate 12-month smoking cessation success rates among smokers using bupropion versus those using NRT in a real-world clinical setting. Methodology: This prospective observational cohort study included 235 adult smokers who visited a Smoking Cessation Clinic affiliated with the Community Health Center in Giresun, Turkey, between October 2022 to October 2023. All participants received physician-led counseling and were prescribed either bupropion (n=45) or NRT (n=190; NRT 15 mg, n=118, and NRT 25 mg, n=72). Both treatments were provided free of charge for 12 weeks, during which six scheduled clinical visits were conducted over a 90-day period. Telephone follow-up assessments were conducted at weeks 16, 24 and 52. The primary outcome was the self-reported continuous abstinence at week 52.

Results

The mean age of participants was 40.74 ± 12.42 years, with 59.6% (n=140) being men. The overall 12-month continuous abstinence rate was 69.4% (n=163). The independent predictors of sustained abstinence at 52 weeks were high adherence to treatment, regular attendance at scheduled follow-up visits, counseling along with bupropion or high-dose NRT (25 mg), and fewer adverse effects during treatment.

Conclusion

In real-world clinical practice, bupropion or high-dose NRT (25 mg), combined with structured counseling yielded high long-term abstinence rates and acceptable side effect profiles.

Schlagwörter

Stichwörter der Autor:innen

BupropionCohort studyNicotine replacement therapyPharmacotherapySmoking cessationTobacco dependence

Autor:innen und Institutionen

  • Neslisah Gurel Koksal, MD Department of Family Medicine, Giresun University Giresun Training, Research Hospital, Giresun, Turkey.
  • Mustafa Koksal, MD Giresun Provincial Directorate of Health, Giresun, Turkey.

Zitieren

APA

Koksal, N. G., & Koksal, M. (2026). One-year comparative effectiveness of bupropion and nicotine replacement therapy in smoking cessation: A prospective observational cohort study in Turkey. Pakistan Journal of Medical Sciences, 42(4), 979-985. https://doi.org/10.12669/pjms.42.4.13527

Vancouver

Koksal NG, Koksal M. One-year comparative effectiveness of bupropion and nicotine replacement therapy in smoking cessation: A prospective observational cohort study in Turkey. Pakistan Journal of Medical Sciences. 2026;42(4):979-985. doi:10.12669/pjms.42.4.13527

BibTeX
@article{Koksal2026,
  author = {Koksal, Neslisah Gurel and Koksal, Mustafa},
  title = {One-year comparative effectiveness of bupropion and nicotine replacement therapy in smoking cessation: A prospective observational cohort study in Turkey},
  journal = {Pakistan Journal of Medical Sciences},
  year = {2026},
  volume = {42},
  number = {4},
  pages = {979--985},
  doi = {10.12669/pjms.42.4.13527}
}
Kostenlos starten →